Site Search

... is asking the legislature to prioritize access to care for cancer patients through the expansion of telehealth services and increased access to biomarker testing. Telehealth is critical because it provides cancer patients and survivors with a convenient means of accessing some cancer care and primary ... ‘the right treatment, to the right patient, at the right time,’ precision medicine plays a critical role in improving cancer outcomes, and biomarker testing is an essential step to precision medicine. Legislative action on these pieces of legislation would improve access to care for ...

... state leaders to discuss our cancer legislative and budget priorities.  Cancer Action Week Legislative Asks: Expand coverage and access to biomarker testing. Pass copay accumulator legislation (S3818/A5217), which would improve access to prescription drugs by ensuring copay assistance is counted ... Maintain funding for the New Jersey Cancer Education and Early Detection Screening Program (NJCEED) at $5 Million. Event Resources: New Jersey Biomarker one pager New Jersey Step Therapy Copay Accumulator  New Jersey Commission on Cancer Research  New Jersey Cancer Education and Early ...

... products. We will be making the following fact-based policies a priority and ask for your support:   Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for House Bill 180, which improves coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...

... and comprehensive health insurance including Medicaid and will support efforts to curb the availability of inadequate health plans. Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Progress in improving cancer outcomes increasingly involves the use of precision medicine, which uses information about a ...